18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies

B B Chin; R L Wahl

doi:10.1136/gut.52.suppl_4.iv23

18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies

Gut. 2003 Jun;52 Suppl 4(Suppl 4):iv23-9. doi: 10.1136/gut.52.suppl_4.iv23.

Authors

B B Chin¹, R L Wahl

Affiliation

¹ Johns Hopkins School of Medicine, Department of Radiology, Division of Nuclear Medicine, Baltimore, USA. chin004@mc.duke.edu

Abstract

Positron emission tomography with (18)F-fluoro-2-deoxyglucose is an imaging technology that is demonstrating increasing utility in the evaluation of gastrointestinal malignancies.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Adult
Colorectal Neoplasms / diagnostic imaging
Digestive System Neoplasms / diagnostic imaging*
Esophageal Neoplasms / diagnostic imaging
Female
Fluorodeoxyglucose F18
Humans
Male
Middle Aged
Pancreatic Neoplasms / diagnostic imaging
Radiopharmaceuticals
Stomach Neoplasms / diagnostic imaging
Tomography, Emission-Computed / methods*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18